Prestige Consumer Healthcare Inc. (PBH) is a publicly traded Healthcare sector company. As of July 15, 2026, PBH trades at $48.34 with a market cap of $2.24B and a P/E ratio of 12.21. PBH moved +2.48% today. Year to date, PBH is -21.61%; over the trailing twelve months it is -35.65%. Its 52-week range spans $42.62 to $90.04. Analyst consensus is buy with an average price target of $72.00. Rallies surfaces PBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PBH, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $48.34 |
| Market Cap | $2.24B |
| P/E Ratio | 12.21 |
| EPS | $3.93 |
| Dividend Yield | 0.31% |
| 52-Week High | $90.04 |
| 52-Week Low | $42.62 |
| Volume | 310.45K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.09B |
| Net Income | $190.30M |
| Gross Margin | 54.70% |
3 analysts cover PBH: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $72.00.